A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引：456
作者：
PETRELLI, N
HERRERA, L
RUSTUM, Y
BURKE, P
CREAVEN, P
STULC, J
EMRICH, LJ
MITTELMAN, A
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THERAPEUT,BUFFALO,NY 14263
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOMATH,BUFFALO,NY 14263
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 10期
关键词：
D O I：
10.1200/JCO.1987.5.10.1559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1559 / 1565
页数：7
相关论文
共 20 条
  • [1] ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO
  • [2] 2-2
  • [3] BRUCKNER HW, 1983, P AM ASSOC CANC RES, V24, P138
  • [4] BYRNE P, 1983, P AM SOC CLIN ONCOL, V2, P121
  • [5] CUNNINGHAM J, 1984, INVEST NEW DRUG, V2, P391
  • [6] DAVIS HL, 1982, CANCER-AM CANCER SOC, V50, P2638
  • [7] CHEMOTHERAPY OF ADVANCED COLORECTAL-CARCINOMA - FLUOROURACIL ALONE VS 2 DRUG-COMBINATIONS USING FLUOROURACIL, HYDROXYUREA, SEMUSTINE, DACARBAZINE, RAZOXANE, AND MITOMYCIN - A PHASE-III TRIAL BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (EST-1278)
    ENGSTROM, PF
    MACINTYRE, JM
    MITTELMAN, A
    KLAASSEN, DJ
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (04): : 313 - 318
  • [8] EVANS RM, 1981, CANCER RES, V41, P3283
  • [9] HEIDELBERGER C, 1975, HDB EXPT PHARMAKOLOG, V38, P193
  • [10] HOUGHTON JA, 1981, CANCER RES, V41, P144
12